Prospective Registry of Solitaire FR Endovascular Recanalization Treatment for Acute Stroke - Post Market Surveillance in Japan

Prospective Registry of Solitaire FR Endovascular Recanalization Treatment for Acute Stroke - Post Market Surveillance in Japan - Study of safety And efficacy on Post MarKeting SUrveillance of Solitaire FR for cerebral Acute Stroke (SAKURA)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014483

Enrollment

240

Registered

2014-07-07

Start date

2014-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute stroke

Interventions

Slitaire FR thrombectomy for acute stroke

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patient who received mechanical thrmobectomy using Solitaire FR 2 Patient who registrate to post market surveillance of Solitaire FR thrombectomy

Exclusion criteria

Exclusion criteria: not determined

Design outcomes

Primary

Measure	Time frame
modified Rankin Scale 0-2 90days after treatment	—

Secondary

Measure	Time frame
1. recanalization of target artery 2. mRS 0-1 90days after treatment 3. change in NIHSS 4. relation between recanalization and prognosis 5. symptomatic intracranial hemorrhage within 24 hours 6. death within 90days 7. adverse event	—

Countries

Japan

Contacts

Public ContactNobuyuki Sakai

Kobe City Medical Center General Hospital Neurosurgery

n.sakai@siren.ocn.ne.jp0783024321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026